LivaNova (LIVN) Liabilities and Shareholders Equity (2015 - 2026)

LivaNova (LIVN) reported Liabilities and Shareholders Equity of $2.5 billion for Q1 2026, down 1.66% on a YoY basis from $2.6 billion in Q1 2025, and down 3.44% sequentially from $2.6 billion in Q4 2025.

LivaNova (LIVN) Liabilities and Shareholders Equity (2015 - 2026) Analysis & Trends

LivaNova (LIVN) has 12 years of Liabilities and Shareholders Equity data on file, last reported at $2.5 billion in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 1.66% year-over-year to $2.5 billion; the trailing twelve-month figure through Mar 2026 stood at $10.2 billion (up 20.66% YoY), and the FY2025 full-year result was $2.6 billion, up 3.98% from the prior year.
  • Liabilities and Shareholders Equity eased to $2.5 billion in Q1 2026, from $2.6 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.6 billion in Q4 2025 to a low of $855.1 million in Q2 2024.
  • A 5-year average of $2.3 billion and a median of $2.4 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • Across the five-year window, Liabilities and Shareholders Equity tumbled 63.48% in 2024 and surged 193.15% in 2025, its largest moves.
  • Tracing LIVN's Liabilities and Shareholders Equity over 5 years: stood at $2.3 billion in 2022, then advanced by 5.87% to $2.4 billion in 2023, then grew by 3.16% to $2.5 billion in 2024, then advanced by 3.98% to $2.6 billion in 2025, then dropped by 3.44% to $2.5 billion in 2026.
  • Business Quant data shows LIVN's Liabilities and Shareholders Equity at $2.5 billion in Q1 2026, $2.6 billion in Q4 2025, and $2.6 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 110.43 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 46.29 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 6.63 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 31.92 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 37.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 10.46 Bn
10 LivaNova 4.30 Bn 3.76 Bn 243.75 Mn 2.52 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.52 Bn
Dec 31, 2025 2.61 Bn
Sep 30, 2025 2.56 Bn
Jun 30, 2025 2.51 Bn
Mar 31, 2025 2.56 Bn
Dec 31, 2024 2.51 Bn
Sep 30, 2024 2.52 Bn
Jun 30, 2024 855.10 Mn
Mar 31, 2024 2.46 Bn
Dec 31, 2023 2.43 Bn
Sep 30, 2023 2.33 Bn
Jun 30, 2023 2.34 Bn
Mar 31, 2023 2.29 Bn
Dec 31, 2022 2.29 Bn
Sep 30, 2022 2.21 Bn
Jun 30, 2022 2.34 Bn
Mar 31, 2022 2.42 Bn
Dec 31, 2021 2.20 Bn
Sep 30, 2021 2.20 Bn
Jun 30, 2021 2.40 Bn